HomeGroupsTalkZeitgeist
Check out the Pride Celebration Treasure Hunt!
This site uses cookies to deliver our services, improve performance, for analytics, and (if not signed in) for advertising. By using LibraryThing you acknowledge that you have read and understand our Terms of Service and Privacy Policy. Your use of the site and services is subject to these policies and terms.
Hide this

Results from Google Books

Click on a thumbnail to go to Google Books.

New Drugs: An Insider's Guide to the…
Loading...

New Drugs: An Insider's Guide to the FDA's New Drug Approval… (edition 2009)

by Lawrence T. Friedhoff (Author)

MembersReviewsPopularityAverage ratingConversations
4None2,429,975NoneNone
Member:ACAsmaraLibrary
Title:New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients
Authors:Lawrence T. Friedhoff (Author)
Info:PSPG Publishing (2009), Edition: 1, 258 pages
Collections:Your library
Rating:
Tags:None

Work details

New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients by Lawrence T. Friedhoff

None.

None
Loading...

Sign up for LibraryThing to find out whether you'll like this book.

No current Talk conversations about this book.

No reviews
no reviews | add a review
You must log in to edit Common Knowledge data.
For more help see the Common Knowledge help page.
Series (with order)
Canonical title
Original title
Alternative titles
Original publication date
People/Characters
Important places
Important events
Related movies
Awards and honors
Epigraph
Dedication
First words
Quotations
Last words
Disambiguation notice
Publisher's editors
Blurbers
Publisher series
Original language
Canonical DDC/MDS

References to this work on external resources.

Wikipedia in English (1)

Book description
Haiku summary

Amazon.com Product Description (ISBN 141969961X, Paperback)

Drug development, the processes by which a chemical compound becomes a “drug” and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and tactical considerations play out in an environment where a balance must be struck between the often-competing interests of the corporation, its investors, government regulators, and the safety and well being of intended patients. All the while, dwindling patent protections impose an ever-contracting timeframe for success. Written to be accessible to a wide audience, NEW DRUGS provides a thorough, succinct, and practical understanding of these drug-development processes. If you’re involved in the pharmaceutical industry, NEW DRUGS will provide scientific and management tools to increase the likelihood of regulatory approval at each phase of your compound’s development. If you’re a patient or consumer, NEW DRUGS will enable you to intelligently discuss medications with your health-care provider and empower you to make informed decisions at the pharmacy. If your portfolio, rather than your health, makes you an interested observer of the fortunes of this critical sector of the US economy, NEW DRUGS will help you to decode press releases and annual reports, so that you can recognize and invest in well-run companies with promising products.

(retrieved from Amazon Thu, 12 Mar 2015 18:18:24 -0400)

No library descriptions found.

Quick Links

Popular covers

Rating

Average: No ratings.

Is this you?

Become a LibraryThing Author.

 

About | Contact | Privacy/Terms | Help/FAQs | Blog | Store | APIs | TinyCat | Legacy Libraries | Early Reviewers | Common Knowledge | 135,476,276 books! | Top bar: Always visible